Douglas J Swirsky - Net Worth and Insider Trading
Douglas J Swirsky Net Worth
The estimated net worth of Douglas J Swirsky is at least $197,142 dollars as of 2024-04-23. Douglas J Swirsky is the President & CEO of Genvec Inc and owns about 25,250 shares of Genvec Inc (GNVC) stock worth over $181,623. Douglas J Swirsky is the Director of Cellectar Biosciences Inc and owns about 2,500 shares of Cellectar Biosciences Inc (CLRB) stock worth over $7,975. Douglas J Swirsky is also the President and CEO of Rexahn Pharmaceuticals Inc and owns about 1,042 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $7,544. Details can be seen in Douglas J Swirsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas J Swirsky has not made any transactions after 2021-09-14 and currently still holds the listed stock(s).
Transaction Summary of Douglas J Swirsky
Douglas J Swirsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas J Swirsky owns 8 companies in total, including NeuroBo Pharmaceuticals Inc () , Cellectar Biosciences Inc () , and Fibrocell Science Inc () among others .
Click here to see the complete history of Douglas J Swirsky’s form 4 insider trades.
Insider Ownership Summary of Douglas J Swirsky
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NeuroBo Pharmaceuticals Inc | 2020-09-01 | director | |
Cellectar Biosciences Inc | 2021-09-14 | director | |
Fibrocell Science Inc | 2019-12-13 | director | |
Rexahn Pharmaceuticals Inc | 2019-01-29 | director & President and CEO | |
Pernix Therapeutics Holdings Inc | 2018-05-22 | director | |
Genvec Inc | 2017-06-16 | director & President and CEO | |
Ocuphire Pharma Inc | 2018-01-02 | President and CFO | |
MaxCyte Inc | 2023-03-27 | Chief Financial Officer |
Douglas J Swirsky Latest Holdings Summary
Douglas J Swirsky currently owns a total of 3 stocks. Among these stocks, Douglas J Swirsky owns 25,250 shares of Genvec Inc (GNVC) as of September 16, 2016, with a value of $181,623 and a weighting of 92.13%. Douglas J Swirsky owns 2,500 shares of Cellectar Biosciences Inc (CLRB) as of September 14, 2021, with a value of $7,975 and a weighting of 4.05%. Douglas J Swirsky also owns 1,042 shares of Rexahn Pharmaceuticals Inc (REXN) as of January 29, 2019, with a value of $7,544 and a weighting of 3.83%.
Latest Holdings of Douglas J Swirsky
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GNVC | Genvec Inc | 2016-09-16 | 25,250 | 7.19 | 181,623 |
CLRB | Cellectar Biosciences Inc | 2021-09-14 | 2,500 | 3.19 | 7,975 |
REXN | Rexahn Pharmaceuticals Inc | 2019-01-29 | 1,042 | 7.24 | 7,544 |
Holding Weightings of Douglas J Swirsky
Douglas J Swirsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas J Swirsky has made a total of 0 transactions in Genvec Inc (GNVC) over the past 5 years. The most-recent trade in Genvec Inc is the acquisition of 1,000 shares on September 16, 2016, which cost Douglas J Swirsky around $5,000.
According to the SEC Form 4 filings, Douglas J Swirsky has made a total of 1 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 2,500 shares on September 14, 2021, which cost Douglas J Swirsky around $26,000.
According to the SEC Form 4 filings, Douglas J Swirsky has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the acquisition of 1,042 shares on January 29, 2019, which cost Douglas J Swirsky around $31,500.
Insider Trading History of Douglas J Swirsky
- 1
Douglas J Swirsky Trading Performance
GuruFocus tracks the stock performance after each of Douglas J Swirsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas J Swirsky is -18.64%. GuruFocus also compares Douglas J Swirsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas J Swirsky within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas J Swirsky's insider trading performs compared to the benchmark.
Performance of Douglas J Swirsky
Average Return
-36.93%
Outperforming Transactions
22%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -9.04 | -18.64 | -14.77 | -36.93 | -46.14 | -20.74 |
Relative Return to S&P 500(%) | -10.73 | -21.01 | -19.9 | -36.37 | -45.76 | -23.56 |
Douglas J Swirsky Ownership Network
Ownership Network List of Douglas J Swirsky
Ownership Network Relation of Douglas J Swirsky
Douglas J Swirsky Owned Company Details
What does NeuroBo Pharmaceuticals Inc do?
Who are the key executives at NeuroBo Pharmaceuticals Inc?
Douglas J Swirsky is the director of NeuroBo Pharmaceuticals Inc. Other key executives at NeuroBo Pharmaceuticals Inc include Acting Chief Financial Officer Marshall H Woodworth , Interim CEO and President Joseph Hooker , and 10 percent owner Goldman Sachs Group Inc .
NeuroBo Pharmaceuticals Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NeuroBo Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeuroBo Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NeuroBo Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuroBo Pharmaceuticals Inc Insider Transactions
Douglas J Swirsky Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas J Swirsky. You might contact Douglas J Swirsky via mailing address: C/o Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road Suite 455, Rockville Md 20850.